These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1438618)
21. Serotonergic function in panic disorder: endocrine responses to D-fenfluramine. Judd FK; Apostolopoulos M; Burrows GD; Norman TR Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):329-37. PubMed ID: 8208982 [TBL] [Abstract][Full Text] [Related]
22. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion. Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833 [TBL] [Abstract][Full Text] [Related]
23. Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts. Handelsman L; Kahn RS; Sturiano C; Rinaldi PJ; Gabriel S; Schmeidler JP; Bernstein DP; Siever L; Cooper TB Psychiatry Res; 1998 Jul; 80(1):1-12. PubMed ID: 9727959 [TBL] [Abstract][Full Text] [Related]
24. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Veith RC; Lewis N; Linares OA; Barnes RF; Raskind MA; Villacres EC; Murburg MM; Ashleigh EA; Castillo S; Peskind ER Arch Gen Psychiatry; 1994 May; 51(5):411-22. PubMed ID: 8179465 [TBL] [Abstract][Full Text] [Related]
25. Serotonin-mediated phosphorylation of extracellular regulated kinases in platelets of patients with panic disorder versus controls. Martini C; Trincavelli ML; Tuscano D; Carmassi C; Ciapparelli A; Lucacchini A; Cassano GB; Dell'Osso L Neurochem Int; 2004 Jun; 44(8):627-39. PubMed ID: 15016478 [TBL] [Abstract][Full Text] [Related]
26. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia. Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048 [TBL] [Abstract][Full Text] [Related]
27. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615 [TBL] [Abstract][Full Text] [Related]
28. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Stein MB; Uhde TW Biol Psychiatry; 1988 Jul; 24(3):322-30. PubMed ID: 2840978 [TBL] [Abstract][Full Text] [Related]
29. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Zohar J; Insel TR Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259 [TBL] [Abstract][Full Text] [Related]
34. Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase. Sulser F; Gillespie DD; Mishra R; Manier DH Ann N Y Acad Sci; 1984; 430():91-101. PubMed ID: 6331266 [TBL] [Abstract][Full Text] [Related]
35. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Coplan JD; Papp LA; Pine D; Martinez J; Cooper T; Rosenblum LA; Klein DF; Gorman JM Arch Gen Psychiatry; 1997 Jul; 54(7):643-8. PubMed ID: 9236548 [TBL] [Abstract][Full Text] [Related]
36. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia. Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722 [TBL] [Abstract][Full Text] [Related]
37. Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism. George DT; Nutt DJ; Rawlings RR; Phillips MJ; Eckardt MJ; Potter WZ; Linnoila M Biol Psychiatry; 1995 Jan; 37(2):112-9. PubMed ID: 7718674 [TBL] [Abstract][Full Text] [Related]
38. Biological and clinical validation of atypical depression. McGinn LK; Asnis GM; Rubinson E Psychiatry Res; 1996 Mar; 60(2-3):191-8. PubMed ID: 8723310 [TBL] [Abstract][Full Text] [Related]
39. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms. Schwartz PJ; Murphy DL; Wehr TA; Garcia-Borreguero D; Oren DA; Moul DE; Ozaki N; Snelbaker AJ; Rosenthal NE Arch Gen Psychiatry; 1997 Apr; 54(4):375-85. PubMed ID: 9107154 [TBL] [Abstract][Full Text] [Related]
40. Do noradrenergic reuptake inhibitors affect serotonergic function in depression? Cleare AJ; Murray RM; O'Keane V Psychopharmacology (Berl); 1997 Dec; 134(4):406-10. PubMed ID: 9452184 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]